ChangAn Opens First International NEV Manufacturing Base in Thailand, Expanding Its Industry Export Model
RAYONG, Thailand, May 18, 2025 /CNW/ -- ChangAn Automobile ("ChangAn" or "the Company"), an intelligent low-carbon mobility technology company, has accelerated its Vast Ocean Plan for global expansion with the launch of production at its first international new energy vehicle (NEV) production base in Rayong, Thailand. The facility marks a transition from product exports to exporting entire industrial ecosystems. The Rayong factory incorporates manufacturing systems, R&D processes, and supply chain standards, establishing a green, intelligent, and replicable model for sustainable global operations.
Coinciding with the launch of the Rayong factory, ChangAn also celebrated the rollout of its 28.59 millionth vehicle, a right-hand drive DEEPAL S05 tailored for global markets. This milestone underscores ChangAn's commitment to its Vast Ocean Plan, which aims to elevate five major overseas markets—Southeast Asia, the Middle East and Africa, Central and South America, Europe, and Eurasia—to the same strategic level as its home market in China. By scaling globally with smart manufacturing and localised collaboration, ChangAn is accelerating its transformation into a world-class automobile brand.
The Rayong factory spans approximately 245 rai (392,000 square meters), and boasts five workshops, including welding, painting, general assembly, engine assembly, and battery, plus auxiliary functions such as exterior inspection. As a green, energy-efficient facility, it features streamlined operations with daylight optimisation, photovoltaic systems, and greywater/rainwater recycling, reducing per-vehicle energy consumption by around 20%. Automated processes, adaptive conveyance systems, and advanced assembly and testing ensure production efficiency and product quality for diverse market demands. In the future, the CHANG-AN, DEEPAL, and AVATR brands will be produced at the Rayong Factory, with annual capacity expected to double from 100,000 to 200,000 units by 2027.
ChangAn's Vast Ocean Plan reflects global industry trends, with the Rayong Factory marking a major step in its international operation. To date, ChangAn has held brand launches in Mexico, Saudi Arabia, and Germany. In particular, since launching its Southeast Asia brand initiative in Thailand in November 2023, the company has introduced seven new models to the Thai market including the DEEPAL S07, E07, and AVATR 11, with cumulative sales exceeding 14,000 units, ranking among the top four in Thailand's NEV market.
ChangAn's Rayong factory marks the culmination of 41 years of automotive manufacturing expertise. Blending this legacy with local operations, the facility has established a global system standard cultivating international talent. It sets the foundation for replicating ChangAn's global factory standards and serves as a best-practice model for international operations, reflected in four key areas, namely, the application of ChangAn's CPS lean manufacturing system, emphasising leadership, productivity, and performance. The integration of seven operational systems and six core processes forms the core of the Company's lean management strategy, reflecting its commitment to excellence. Leveraging the CAPDS system, the plant strengthens Southeast Asian technical support and engineering development. It focuses on new energy, intelligent systems, adaptive design, and advancing regional product innovation. Built on the CA-PLS framework, Rayong is ChangAn's first international site to standardise production management enabling rapid product launches. The plant marks an innovative, resilient, dual-circulation supply chain linking China and Thailand.
"This is a big moment for ChangAn – a giant leap from exporting cars to building local ecosystem," said Zhu Huarong, Chairman of ChangAn Automobile. "Despite the huge challenges brought by anti-globalization, ChangAn stays committed to Vast Ocean Plan. With a spirit of win-win cooperation, we will contribute more to economic and social development of Thailand, and drive the global auto industry forward."
View original content to download multimedia:https://www.prnewswire.com/news-releases/changan-opens-first-international-nev-manufacturing-base-in-thailand-expanding-its-industry-export-model-302458660.html
SOURCE ChangAn Automobile
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/19/c7057.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
HERZLIYA, Israel and CALGARY, AB, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada. PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative. Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency. LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions. "We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan. "This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field." About Innocan: Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales. Contact Information: For Innocan Pharma Corporation:Iris Bincovich, CEO+1 5162104025+972-54-3012842+442037699377info@ NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Caution Regarding Forward-Looking Information Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law. Logo: View original content: SOURCE Innocan Pharma Corporation View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Squaremouth Reports on Global Airbnb Crackdown: What Travelers Need to Know
ST. PETERSBURG, Fla., June 20, 2025 /PRNewswire/ -- Governments across Europe and Asia are cracking down on international rentals. Last month, Spain ordered Airbnb to delist 65,000 rentals. Earlier this year, Thailand issued a warning to foreigners buying apartments and renting them out that they are violating Thai law. Other popular countries, like Italy and Greece, have implemented their own similar measures. These new laws and regulations come on the brink of the busy summer travel season, when traveler anxiety is already skyrocketing. Squaremouth, the nation's largest travel insurance comparison service, reveals what you need to know before booking your trip this summer. How These Crackdowns May Impact your Trip The crackdowns across Spain, Italy, Thailand, Greece, and other regions are part of a larger push to address housing inequality and overtourism. Crackdowns like these can leave travelers in a bind and cost them money, especially if accommodations are suddenly canceled or become unavailable. This happened to a Squaremouth employee recently, who had her rental suddenly canceled at the last minute. "We had an Airbnb booked in Bangkok, but Thailand had just issued a ban on short-term rentals in apartments and condos because they say it disrupts the public," said Arielle Turriff, Product Development Manager at Squaremouth. "Our booking got canceled, and since a lot of our plans were based around that area, we had to find a hotel nearby last minute. It ended up costing us an extra $500." Does Travel Insurance Cover Airbnbs? Travel insurance can cover Airbnb stays and other vacation rentals as long as you have Trip Cancellation and Trip Interruption coverage. However, these benefits only reimburse you if you cancel for a covered reason, like an illness or severe weather that prevents you from traveling. Most plans do not cover government restrictions. If you're staying in an Airbnb and want complete flexibility, opt for a policy with Cancel For Any Reason (CFAR) coverage. CFAR is an upgrade that offers partial reimbursement for prepaid and non-refundable trip payments if you need to cancel your trip for a reason not otherwise covered by Trip Cancellation, such as a government crackdown on Airbnbs. CFAR is a popular benefit for many travelers, as it provides the most possible flexibility when it comes to canceling a trip. In fact, Squaremouth has seen a 34% increase in travelers purchasing CFAR compared to last summer. Squaremouth's Tips for Enjoying your Summer Vacation Rental Always purchase travel insurance as soon as you book your Airbnb to maximize your coverage window, especially for Trip Cancellation benefits. Heed local government notices and warnings when it comes to disruptions. For maximum flexibility and peace of mind, consider Cancel For Any Reason (CFAR) coverage. About Squaremouth Squaremouth is a trusted name in the travel insurance industry offering comprehensive, transparent, and competitive coverage to travelers for 20 years through its digital platform. With the largest portfolio of travel insurance carriers and products in the U.S., Squaremouth has insured over 4 million clients. Media Contact Ned Tadic ntadic@ View original content to download multimedia: SOURCE Squaremouth
Newsweek
4 days ago
- Newsweek
Thailand Plots Huge Economic Success With $1.2 Billion Bangkok F1 Race
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Thai government has officially sanctioned a budget of $1.2 billion to host a Grand Prix in the capital city of Bangkok. With several Grand Prix venues reporting a significant economic impact through Formula One, Thailand is eager to host a street race. A 3.54-mile street circuit is being planned through the Chatuchak Park area, and the inaugural race is expected to take place in three years. A report by Autosport states that Thailand and F1 will enter into a five-year contract starting in 2028. The confirmation of a street race in Bangkok arrives months after F1 CEO Stefano Domenicali met with Thailand's Prime Minister Paetongtarn Shinawatra to discuss the ambitious plan. Considering the economic boom local economies experience through F1 races, the global demand for F1 is witnessing an upward trend. Oscar Piastri of Australia driving the (81) McLaren MCL39 Mercedes leads the field into turn one at the start during the F1 Grand Prix of Spain at Circuit de Barcelona-Catalunya on June 01, 2025 in... Oscar Piastri of Australia driving the (81) McLaren MCL39 Mercedes leads the field into turn one at the start during the F1 Grand Prix of Spain at Circuit de Barcelona-Catalunya on June 01, 2025 in Barcelona, Spain. MoreThe news of setting aside $1.2 billion for the event was announced by tourism minister Sorawong Thienthong in a press conference. Government spokesperson Jirayu Houngsub revealed his confidence in hosting an F1 race. He said: "In the next two-three years, Thailand will have world-class competition, which we never thought would happen in Thailand." While Thailand is gearing up to potentially have its first race in Bangkok, F1 announced a fresh contract extension for the Canadian GP yesterday, which secured its spot on the F1 calendar for the next ten years. The new four-year deal extended Montreal's validity on the calendar from 2031 to 2035. Newsweek Sports reported the comments of Stefano Domenicali. He said: "As Formula 1 celebrates its 75th anniversary, it is fitting that we have announced an extension with the Canadian Grand Prix, a race that has such incredible history in our sport and is named after a true legend in Gilles Villeneuve. "Montreal is an incredible city, full of energy and passionate fans, and I am delighted to confirm that we will continue racing here through to the 2035 season and that our media rights deal with Bell Media is also extending in the long term. "I would like to thank the promoter, Octane Racing Group, for their continued efforts in upgrading this iconic venue in recent years, and all local, regional, and national political stakeholders who have worked closely together to make this event what it is today. "I would also like to thank our incredible Canadian fans. I look forward to creating more unforgettable moments in Montréal with you over the next 10 years." The announcement of the new Canadian GP deal and the upcoming race in Bangkok highlight the high demand for F1. But with the sport operating at its limit with the current 24-race calendar, it has had to drop iconic circuits such as Imola from the 2026 calendar, while Barcelona's future for 2027 remains uncertain.
